Table 1. Demographic Characteristics and Epilepsy Phenotypes.
Characteristic | No. (%) (Nā=ā522) |
---|---|
Sex | |
Male | 269 (51.5) |
Female | 253 (48.5) |
Age at seizure onset | |
Mean (SD), y | 1.2 (1.4) |
Neonatal (<1 mo) | 20 (3.8) |
Infantile (1 to <12 mo) | 105 (20.1) |
Early childhood (1 to <6 y) | 229 (43.9) |
School-aged (6 to <14 y) | 135 (25.9) |
Adolescent (ā„14 y) | 33 (6.3) |
Epilepsy type | |
DEE | 142 (27.2) |
Non-DEE | |
GGE | 127 (24.3) |
IGE | 53 (10.2) |
NAFE | 152 (29.1) |
Combined generalized and focal | 48 (9.2) |
Epilepsy syndrome diagnoses | |
Syndromes associated with refractory seizures or developmental comorbidities | |
Any | 118 (22.8) |
Infantile epileptic spasms syndrome | 46 (8.8) |
Lennox-Gastaut syndrome | 24 (4.6) |
Epilepsy with myoclonic-atonic seizures | 11 (2.1) |
Epilepsy with eyelid myoclonia | 9 (1.7) |
Spike-and-wave activation in sleep | 7 (1.3) |
Landau-Kleffner syndrome | 5 (1) |
Sleep-related hypermotor epilepsy | 4 (0.8) |
Myoclonic epilepsy in infancy | 4 (0.8) |
Dravet syndrome | 3 (0.6) |
Epilepsy of infancy with migrating focal seizures | 2 (0.4) |
Febrile infection-related epilepsy syndrome | 2 (0.4) |
Hemiconvulsion-hemiplegia epilepsy syndrome | 1 (0.2) |
Syndromes associated with milder prognosis | |
Any | 75 (14.4) |
Childhood absence epilepsy | 34 (6.5) |
Self-limited epilepsy with centrotemporal spikes | 16 (3.1) |
Juvenile myoclonic epilepsy | 14 (2.7) |
Juvenile absence epilepsy | 3 (0.6) |
Self-limited infantile epilepsy | 3 (0.6) |
Self-limited epilepsy with autonomic seizures | 2 (0.4) |
Epilepsy with generalized tonic-clonic seizures alone | 1 (0.2) |
Self-limited focal epilepsy | 1 (0.2) |
Photosensitive occipital lobe epilepsy | 1 (0.2) |
Responsive to ASMs (seizure-free) | 222 (46.4) |
Intellectual disability | |
None | 259 (49.6) |
Borderline | 74 (14.2) |
Mild | 79 (15.1) |
Moderate | 59 (11.3) |
Severe | 38 (7.3) |
Profound | 13 (2.5) |
Other neurodevelopmental diagnoses | |
Presence of ASD | 75 (14.4) |
Presence of ADHD | 71 (13.6) |
Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; ASM, antiseizure medication; DEE, developmental and epileptic encephalopathy; GGE, genetic generalized epilepsy; IGE, idiopathic generalized epilepsy; NAFE, nonacquired focal epilepsy.